Pertussis in older adults: prospective study of risk factors and morbidity Read more about Pertussis in older adults: prospective study of risk factors and morbidity12 views
Tdap: new option for pertussis booster vaccination of seniors Read more about Tdap: new option for pertussis booster vaccination of seniors36 views
The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly Read more about The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly12 views
Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia Read more about Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia26 views
The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules Read more about The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules7 views
Bug Breakfast in the Bulletin: Pertussis in NSW and its prevention in infants and children Read more about Bug Breakfast in the Bulletin: Pertussis in NSW and its prevention in infants and children7 views
The impact of adolescent pertussis immunization, 2004–2009: lessons from Australia Read more about The impact of adolescent pertussis immunization, 2004–2009: lessons from Australia6 views
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: a sub-analysis of four trials Read more about Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: a sub-analysis of four trials115 views
Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in Australia Read more about Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in Australia25 views
A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults Read more about A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults162 views
